Outcomes of adult critically ill patients with hemophagocytic lymphohistiocytosis in united states-analysis from an administrative database from 2007 to 2015

被引:0
|
作者
Kumar, Gagan [1 ]
Hererra, Martin [2 ]
Patel, Dhaval [1 ]
Nanchal, Rahul [3 ]
Guddati, Achuta K. [4 ]
机构
[1] Northeast Georgia Hlth Syst, Dept Pulm & Crit Care, Gainesville, GA 30501 USA
[2] Northeast Georgia Hlth Syst, Dept Internal Med, Gainesville, GA 30501 USA
[3] Med Coll Wisconsin, Div Pulm & Crit Care, Milwaukee, WI 53226 USA
[4] Augusta Univ, Dept Hematol & Oncol, Augusta, GA 30912 USA
来源
AMERICAN JOURNAL OF BLOOD RESEARCH | 2020年 / 10卷 / 06期
关键词
Hemophagocytic lymphohistiocytosis; hemophagocytic syndrome; epidemiology; critical illness;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Severe infections caused by the novel coronavirus 2 display similarities to secondary hemophagocytic lymphohistiocytosis (HLH). However, HLH is a rare disease and has not been well described in critically ill patients. Methods: We used the Nationwide Inpatient Sample (NIS), the largest all-payer inpatient care database publicly available in the United States to identify all adult discharges with Hemophagocytic syndrome (ICD-9 CM code 288.4) between 2007 and 2015. Critical illness was considered present if patient had either ICD-9 CM code indicating the requirement of invasive mechanical ventilation or the presence of shock. We used ICD-9-CM codes to identify various infections (inf-HLH), malignancies (mal-HLH) and autoimmune diseases associated with HLH (MAS-HLH) and classified them in their respective groups. Primary outcome was in-hospital mortality in critically ill patients. We developed multivariable regression model to examine variables associated with mortality in critically ill HLH patients. P value was kept at < 0.05. Results: Of the 7420 (95% CI 6959-7881) estimated discharges with HLH, 2313 (31%) were critically ill. Of the critically ill patients, 442 (34%) were mal-HLH, 422 (43.3%) were inf-HLH, 403 (30.7%) were MAS-HLH and 1046 (27.3%) were unable to be classified. In hospital mortality rates were 6.4% in non-critically ill and 48.4% in critically ill patients. Among the subtypes of HLH, in-hospital mortality was 53% in mal-HLH, 49.4% in inf-HLH, 26% in MAS-HLH and 54.6% in unclassified group. On multivariable regression analysis, development of acute renal failure requiring hemodialysis (OR 2.06, 95% CI 1.29-3.3, P=0.002) and acute hepatic failure (OR 2.21, 95% CI 1.38-3.52, P=0.001) were significantly associated with higher mortality. Conclusion: Inpatient mortality of critically ill patients is remarkably high. Patients with MAS-HLH had better outcomes when compared to other groups of HLH.
引用
收藏
页码:330 / +
页数:11
相关论文
共 50 条
  • [41] Disparities in Newborn Hearing Screening Outcomes in the United States From 2007 to 2017
    Gutierrez, Katie L.
    Koyamatsu, Ryan
    Lahiff, Maureen
    Jutte, Douglas P.
    Chan, Dylan K.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2024, 170 (02) : 535 - 543
  • [42] Differences in clinical characteristics and outcomes between COVID-19 and influenza in critically ill adult patients: A national database study
    Naouri, Diane
    Pham, Tai
    Dres, Martin
    Vuagnat, Albert
    Beduneau, Gaetan
    Mercat, Alain
    Combes, Alain
    Kimmoun, Antoine
    Schmidt, Matthieu
    Demoule, Alexandre
    Jamme, Matthieu
    JOURNAL OF INFECTION, 2023, 87 (02) : 120 - 127
  • [43] Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis
    Stokes, William
    Amini, Arya
    Maroni, Paul D.
    Kessler, Elizabeth R.
    Stokes, Claire
    Cost, Carrye R.
    Greffe, Brian S.
    Garrington, Timothy P.
    Liu, Arthur K.
    Cost, Nicholas G.
    JOURNAL OF PEDIATRIC UROLOGY, 2017, 13 (04) : 386.e1 - 386.e7
  • [44] Treatment Patterns Among Patients with Psoriatic Arthritis Treated with a Biologic in the United States: Descriptive Analyses from an Administrative Claims Database
    Walsh, Jessica A.
    Adejoro, Oluwakayode
    Chastek, Benjamin
    Palmer, Jacqueline B.
    Hur, Peter
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 623 - +
  • [45] THERAPY MODIFICATIONS AMONG PATIENTS WITH PSORIATIC ARTHRITIS TREATED WITH A BIOLOGIC IN THE UNITED STATES - DESCRIPTIVE ANALYSES FROM AN ADMINISTRATIVE CLAIMS DATABASE
    Walsh, J. A.
    Adejoro, O.
    Chastek, B.
    Chun, G.
    Palmer, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 945 - 946
  • [46] Description of an adult spina bifida administrative sample: findings from the United States Veterans Administration Spina Bifida Health Care Program database
    Melissa Danielson
    Judy Thibadeau
    Vincent Campbell
    Cerebrospinal Fluid Research, 6 (Suppl 1):
  • [47] Sepsis influences outcomes from acute renal failure (ARF) in critically ill patients
    Mehta, RL
    Pascual, MT
    Savage, BR
    Soroko, S
    Ikizler, TA
    Paganini, EP
    Himmelfarb, J
    Chertow, GM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 246A - 246A
  • [48] OUTCOMES OF CRITICALLY ILL PATIENTS WITH ALCOHOL ABUSE: RESULTS FROM THE USCIITG-CIOS
    Hirsch, Nina
    Sevransky, Jonathan
    Checkley, William
    Martin, Greg
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [49] Pericardiocentesis Outcomes in Patients With Chronic Kidney Disease : A Nationwide Analysis from the United States
    Ghimire, Manoj
    Poudel, Sajana
    Shrestha, Karun
    Ghimire, Kalpana
    Chamay, Salomon
    Subedi, Prakriti
    Nassar, Sameh
    Pandey, Oshna
    Sherpa, Ninda
    Kadariya, Dinesh
    Baghdadi, Salim
    CIRCULATION, 2024, 150
  • [50] The Intersectionality of Race and Gender in Palliative Care Services Utilization Among Critically-Ill Necrotizing Pancreatitis Patients: Analysis of a Large Nationwide Database in the United States
    Escobar, Tomas Gil
    Quazi, Mohammed A.
    Sohail, Amir Humza
    Butt, Muhammad Ali
    Goyal, Aman
    Sultan, Sulaiman
    Sheikh, Farooq Ali
    Khan, Muhammad Salman
    Sheikh, Abu Baker
    JOURNAL OF PALLIATIVE CARE, 2024,